Skip to content

Clinical trials

Phase 1/2 Hematologic Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 1/2 Country / region: United States Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20031
20041
20065
20074
20082
20094
20103
20112
20123
20134
20145
20153
20162
20173
20183
20195
20203
20219
20225
20233
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Recruiting16
Terminated14
Active, not recruiting10
Withdrawn6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center8
National Cancer Institute (NCI)8
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University4
AstraZeneca2
Baylor College of Medicine2
Bristol-Myers Squibb2
Dana-Farber Cancer Institute2
Fred Hutchinson Cancer Center2
Gamida Cell ltd2
Incyte Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms81
Leukemia, Myeloid, Acute23
Myelodysplastic Syndromes19
Leukemia16
Lymphoma15
Lymphoma, Non-Hodgkin15
Precursor Cell Lymphoblastic Leukemia-Lymphoma13
Multiple Myeloma10
Leukemia, Lymphocytic, Chronic, B-Cell8
Neoplasms8

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.